Long-term postmenopausal hormone therapy and endometrial cancer
about
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort.Menopausal hormone therapy and risk of endometrial cancer.Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancerHormonal and reproductive risk factors for sporadic microsatellite stable and unstable endometrial tumors.Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancerBody Mass Index Genetic Risk Score and Endometrial Cancer Risk.Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?An aggregated analysis of hormonal factors and endometrial cancer risk by parityContinuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.Body size over the life-course and the risk of endometrial cancer: the California Teachers Study.Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors oNovel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
P2860
Q30413346-8E90E60F-2F9D-42EA-A037-53A75EE85755Q34042346-2045CBCE-6684-494B-B7E2-D6E004842604Q34078827-85A35DEF-E99C-4FA3-AA25-802A089DB940Q34345110-B437E2C7-BF67-4876-B470-53B3500F5EE8Q35510465-8F9A77C0-069D-42AB-B2BF-8373B12EA0D0Q35568234-CB37DE93-34BC-474A-BE50-EE51BAEC4D6AQ35705758-A2285820-21FF-45AB-8A0F-25AD20605741Q35852637-8E12FA6E-55CC-41AC-A666-A638682E5E20Q36164444-7DCBC29E-5AE6-4A78-9699-0BFD7DE4D4BCQ36189328-89B4D673-683C-48BC-9A96-5428401EB986Q37097950-65456C73-9EE6-4FC9-8AE7-ADCA2B63AC90Q37353846-3C82B53D-9F3E-4760-BFD3-B060B22B7F97Q40497229-6FD67E66-0EB6-436B-B8E7-AC29E35A99CEQ58592781-020FE7AE-DB67-4CA3-8A6B-343E9D3C3D83Q58790596-AA5801DC-11D1-435A-945D-842C716BB84B
P2860
Long-term postmenopausal hormone therapy and endometrial cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term postmenopausal hormone therapy and endometrial cancer
@ast
Long-term postmenopausal hormone therapy and endometrial cancer
@en
type
label
Long-term postmenopausal hormone therapy and endometrial cancer
@ast
Long-term postmenopausal hormone therapy and endometrial cancer
@en
prefLabel
Long-term postmenopausal hormone therapy and endometrial cancer
@ast
Long-term postmenopausal hormone therapy and endometrial cancer
@en
P2093
P2860
P50
P1476
Long-term postmenopausal hormone therapy and endometrial cancer
@en
P2093
Claire Templeman
Malcolm C Pike
Pedram Razavi
P2860
P304
P356
10.1158/1055-9965.EPI-09-0712
P577
2010-01-19T00:00:00Z